Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eugenio Miglioranza"'
Autor:
Luca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, Paolo Corsi, Davide De Marchi, Eugenio Miglioranza, Giuliana Lista, Ferdinando Daniele Vitelli, Francesca Simonetti, Gian Maria Busetto, Ugo Giovanni Falagario, Martina Maggi, Filippo Marino, Giannicola Genovese, Roberto Falabella, Angelo Porreca
Publikováno v:
Frontiers in Urology, Vol 4 (2024)
IntroductionThis review aims to analyze the existing literature on local recurrence (LR) in patients undergoing partial nephrectomy (PN) for renal cell carcinoma, identifying relative risk factors, and exploring optimal clinical management strategies
Externí odkaz:
https://doaj.org/article/f27a1fdecad54844b34110f040b3e5b4
Autor:
Luca Di Gianfrancesco, Isabella Monia Montagner, Debora Tormen, Alessandro Crestani, Antonio Amodeo, Paolo Corsi, Davide De Marchi, Eugenio Miglioranza, Giuliana Lista, Francesca Simonetti, Gian Maria Busetto, Martina Maggi, Filippo Marino, Antonio Scapinello, Angelo Porreca
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 14, p 4072 (2024)
Background: Programmed death-ligand 1 (PD-L1) expression has been recognized as a potential biomarker for various cancers, yet its diagnostic and prognostic significance in urothelial bladder cancer (BCa) requires further investigation. Methods: In t
Externí odkaz:
https://doaj.org/article/ad62ff5f20bb4020b906513e3418db9d
Autor:
Luca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, Paolo Corsi, Davide De Marchi, Eugenio Miglioranza, Giuliana Lista, Francesca Simonetti, Gian Maria Busetto, Martina Maggi, Francesco Pierconti, Maurizio Martini, Isabella Monia Montagner, Debora Tormen, Antonio Scapinello, Filippo Marino, Angelo Porreca
Publikováno v:
Diagnostics, Vol 13, Iss 19, p 3119 (2023)
Bladder cancer (BCa) is a common type of cancer that affects the urinary bladder. The early detection and management of BCa is critical for successful treatment and patient outcomes. In recent years, researchers have been exploring the use of biomark
Externí odkaz:
https://doaj.org/article/662c8c7583fb4a5a9b10d95caf389d73
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Maruzzo, Umberto Basso, Eugenio Miglioranza, Paolo Corsi, Matteo Sepulcri, Badr El Khouzai, Michele Gregianin, Marta Burei, Antonio Scapinello, Marco Di Martino Russo, Fabrizio Dal Moro, Alessandro Morlacco, Mario Gardi, Laura Evangelista, Marina Paola Gardiman, Daniele Romagnoli, Evelina Lamberti, Alvise Mattana, Vittorina Zagonel, Angelo Porreca
Publikováno v:
Journal of Clinical Oncology. 41:337-337
337 Background: The development of Prostate Cancer Units (PCUs) determined a paradigm shift in the treatment of this disease based on multidisciplinary management and shared clinical pathways among several specialists, but activities of PCUs are rare
Autor:
Giulio Patruno, Francesco Esperto, Eugenio Martorana, Giancarlo Napoli, Saverio Forte, Giorgio Gandaglia, Leonardo Misuraca, Amelia Pietropaolo, Emanuele Principi, Ramona Baldesi, Daniele Parnanzini, Dario Fontana, Francesca Carrobbio, Alfio Corsaro, Giorgio Ivan Russo, Michele Rizzo, Andrea Cocci, Ervin Shehu, Michele Talso, Antonino Battaglia, Roberto La Rocca, Michele Marchioni, Eugenio Miglioranza, Lorenzo Bianchi, Guglielmo Mantica
Background: Numerous surveys have been performed to determine the competence and the confidence of residents. However, there is no data available on the condition of Italian residents in urology. Objective: To investigate the status of training among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad0a1f872b0b1f0c95398e70cd13277
Autor:
Matteo Vittori, Daniele D'Agostino, Angelo Totaro, Giuseppe Palermo, Pierfrancesco Bassi, Alessandro Calarco, Eugenio Miglioranza, Emilio Sacco, Francesco Pinto, Gaetano Gulino, Alessandro D'Addessi, M. Giustacchini, Marco Racioppi
Publikováno v:
Scandinavian Journal of Urology. 47:179-187
High-intensity focused ultrasound (HIFU) is a minimally invasive therapy applied for prostate cancer that capitalizes on the coagulation necrosis that occurs at temperatures greater than 60°C. Owing to a lack of long-term follow-up data the procedur